Circadian variation in fibrinolytic activity in patients with variant angina.
T. Masuda(Kumamoto University), Hirofumi Yasue(Kumamoto City Hospital), Tomohiro Sakamoto(Saiseikai Kumamoto Hospital), Yuji Miyao(National Cerebral and Cardiovascular Center), Hisao Ogawa(Kumamoto University Hospital), Qi Yu(Kumamoto University), Ikuo Misumi(Saiseikai Kumamoto Hospital), Hiroto Okubo(Kumamoto University), Kazuhiro Okumura(Tenri Hospital)
Cited by 47
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755